Taisuke Tsuji

No ORCID on file · 1 paper in corpus
article 2020
·doi:10.1016/j.currproblcancer.2020.100686

Programmed cell death protein 1 immune checkpoint inhibitor is an effective treatment for non-small cell lung cancer. Although hematological immune-related adverse events induced by antiprogrammed-cell-death-protein-1 immunotherapy have bee…